Latest News
ICL Group (NYSE:ICL) reported a stronger first quarter for 2026, with management citing higher bromine and potash prices, broad segment sales growth and operational improvements, while also warning that elevated raw material costs and foreign exchange headwinds remain key risks for the rest of the y
Via MarketBeat · May 13, 2026
Advanced Micro Devices (NASDAQ:AMD) used its 2026 Annual Stockholders Meeting to secure shareholder approval for its director slate and key governance items, while Chair and CEO Lisa Su outlined the company’s growth strategy centered on artificial intelligence and data center computing.
The virtual
Via MarketBeat · May 13, 2026
Ecopetrol (NYSE:EC) reported first-quarter 2026 revenue of COP 28.6 trillion, EBITDA of COP 13.5 trillion and net income of COP 2.9 trillion, as management said stronger refining results and cost controls helped offset currency, logistics and market pressures.
Juan Carlos Hurtado Parra, Ecopetrol’s
Via MarketBeat · May 13, 2026
Flex LNG (NYSE:FLNG) reported first-quarter 2026 net income of $19.5 million, or $0.36 per share, as management said scheduled drydockings and a softer early-quarter spot market weighed on results but improving LNG carrier rates and new contract coverage supported an upgraded full-year outlook.
Chi
Via MarketBeat · May 13, 2026
Franco-Nevada (NYSE:FNV) reported record first-quarter 2026 financial results, with management citing higher precious metals prices, recent acquisitions and strong contributions from several key assets as the main drivers of performance.
President and CEO Paul Brink said the company posted record r
Via MarketBeat · May 13, 2026
Dynatrace (NYSE:DT) reported a stronger finish to fiscal 2026, with executives emphasizing steady annual recurring revenue growth, expanding consumption of its log management products and growing demand tied to artificial intelligence and cloud complexity.
On the company’s fourth-quarter and full-y
Via MarketBeat · May 13, 2026
Cerebras Systems is scheduled to hit the Nasdaq on May 14 in the most anticipated IPO of 2026 so far.
Via The Motley Fool · May 13, 2026
A major investment firm just raised its price target for Plug Power.
Via The Motley Fool · May 13, 2026
This biotech specializes in small molecule kinase inhibitors for cancer, with lead drug candidates in early-stage clinical trials.
Via The Motley Fool · May 13, 2026
Stellantis' turnaround might be gaining steam, and momentum should continue with a sharper focus on four key brands.
Via The Motley Fool · May 13, 2026
Abeona (ABEO) Q1 2026 Earnings Transcript
Via The Motley Fool · May 13, 2026
Rate cuts don’t have to happen tomorrow for these discounted REITs to start looking attractive again.
Via The Motley Fool · May 13, 2026
Altimmune (ALT) Q1 2026 Earnings Transcript
Via The Motley Fool · May 13, 2026
BWX Technologies could be one of the best long-term nuclear plays.
Via The Motley Fool · May 13, 2026
Element Fleet Management and Gildan Activewear are two Canadian dividend stocks with strong fundamentals worth holding in your portfolio for the next five years.
Via The Motley Fool · May 13, 2026

These two chipmakers have two different investment profiles.
Via The Motley Fool · May 13, 2026
Specialty insurance provider Pelagos Insurance (NYSE:PLGO) reported Q1 CY2026 results beating Wall Street’s revenue expectations, but sales fell by 7.3% year...
Via StockStory · May 13, 2026
These Canadian growth stocks have delivered significant gains and are well-positioned to skyrocket further in the next 12 months.
Via The Motley Fool · May 13, 2026
Some institutional investors have been increasing their positions in Lucid stock.
Via The Motley Fool · May 13, 2026
Pool products retailer Leslie’s (NASDAQ:LESL) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 4.3% year on year to $184.7...
Via StockStory · May 13, 2026
Paysign handily beat Wall Street analysts in the first quarter but didn't raise guidance. The stock looks cheap.
Via The Motley Fool · May 13, 2026
This clinical-stage biotech develops targeted radiopharmaceutical therapies for cancer using a proprietary miniprotein platform.
Via The Motley Fool · May 13, 2026
Telecom software provider Amdocs (NASDAQ:DOX) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 3.9% year on year to $1.17 bil...
Via StockStory · May 13, 2026
A good dividend stock offers more than just a high yield, and these two Canadian banks prove exactly why.
Via The Motley Fool · May 13, 2026
These dividend champions have consistently maintained and even increased their dividends regardless of economic uncertainty.
Via The Motley Fool · May 13, 2026